00:03:08 EST Sun 16 Feb 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Therma Bright Inc
Symbol THRM
Shares Issued 451,632,147
Close 2025-02-03 C$ 0.035
Market Cap C$ 15,807,125
Recent Sedar Documents

Therma Bright appoints Raysely to advisory board

2025-02-04 10:38 ET - News Release

Mr. Rob Fia reports

THERMA BRIGHT WELCOMES HEALTHCARE AND TECHNOLOGY EXPERT STEVE RAYSELY TO ITS ADVISORY BOARD

Therma Bright Inc. has added Steve Raysely to its advisory board. With deep experience in health care and technology sales, marketing and operations, Mr. Raysely brings a wealth of expertise to the company's growing advisory team.

Mr. Raysely is a distinguished senior executive and strategic adviser with over two decades of experience driving growth, innovation and operational excellence. Known for his ability to scale businesses and build dynamic go-to-market strategies, Mr. Raysely's expertise encompasses leadership in medical device sales, AI-driven (artificial intelligence) health care solutions and strategic partnership development.

As a trusted adviser to Therma Bright, Mr. Raysely will provide invaluable strategic counsel on product market positioning, commercial expansion and the deployment of emerging health technologies. He draws upon a proven record of identifying high-growth opportunities, optimizing customer experience and delivering sustained revenue growth.

"We are pleased that Steve has agreed to join our advisory board," said Rob Fia, chief executive officer of Therma Bright. "His executive advisory approach centres on scaling distribution operations, pioneering sales and seamlessly integrating advanced technologies to meet evolving market needs. His visionary leadership and outcome-driven approach make him a pivotal asset to company's pursuit of transforming innovation into wellness."

Mr. Raysely joins Mr. Sommerville and Mr. Raimondo on the advisory board -- all of whom are leveraging their networks to introduce Therma Bright, the Venowave VW5, and its other innovative diagnostic and medical device technologies to the U.S. health care marketplace.

Debt settlements

The company also announces that it has negotiated debt settlements with arm's-length creditors. Subject to acceptance by the TSX Venture Exchange, the company proposes to settle aggregate debt of $168,300, in consideration for which it will issue an aggregate of 3,366,000 common shares at a deemed price of five cents per share.

Therma Bright also announces that, further to its press release of Jan. 3, 2025, it has now issued an aggregate of 2,825,000 common shares at a deemed price of four cents per share to settle aggregate debt of $113,000. All shares issued in relation to this debt settlement are subject to a hold period expiring May 4, 2025, in accordance with applicable securities laws and the policies of the TSX Venture Exchange.

About Therma Bright Inc.

Therma Bright is a developer and partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with quality, innovative solutions that address some of today's most important medical and health care challenges. Therma Bright trades on the TSX Venture Exchange under the symbol THRM, on the OTCQB under the symbol TBRIF and on the Frankfurt Stock Exchange under the symbol JNX.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.